MARKET

NXTC

NXTC

NextCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.57
+0.14
+1.48%
Closed 16:29 09/18 EDT
OPEN
9.45
PREV CLOSE
9.43
HIGH
9.57
LOW
9.13
VOLUME
496.45K
TURNOVER
--
52 WEEK HIGH
109.00
52 WEEK LOW
8.00
MARKET CAP
263.68M
P/E (TTM)
-7.5790
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average NXTC stock price target is 23.67 with a high estimate of 55.00 and a low estimate of 11.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NXTC
Nextcure Inc. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases. The Company uses its functional integrated nextcure discovery in immune oncology (FIND-IO) technology to functional screening approaches for the identification of targets from multiple therapeutic areas, including autoimmunity and neurology, enabling immunomedicine to treat unmet medical needs. Its product pipelines include NC318, a immunotherapeutic against a immunomodulatory target found on a restricted set of myeloid and tumor cells, and NC410, a immunomedicine designed to block an immune regulator expressed on T cells and suppressive antigen-presenting cell populations, including dendritic cell subpopulations.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of NextCure Inc stock information, including NASDAQ:NXTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXTC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NXTC stock methods without spending real money on the virtual paper trading platform.